← stocks-llm New chat

GINKGO BIOWORKS HOLDINGS INC CLASS (DNA) — insider trading

Health Care · NYSE

GINKGO BIOWORKS HOLDINGS INC CLASS (DNA) has 43 reported SEC Form 4 insider transactions in our data, including 11 open-market sales among the most recent 43 (latest 2026-06-11).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-06-11 SLOAN HARRY Director Grant / award / vesting (derivative) 25,000 Form 4
2026-06-11 Kosuri Sri Director Grant / award / vesting (derivative) 25,000 Form 4
2026-06-11 Fubini Ross Director Grant / award / vesting (derivative) 25,000 Form 4
2026-06-11 HENRY CHRISTIAN O Director Grant / award / vesting (derivative) 25,000 Form 4
2026-05-22 Coen Steven P. Officer (See remarks) Open-market sale 307 $8.33 $2.6K Form 4
2026-05-21 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 156 Form 4
2026-05-21 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 587 Form 4
2026-05-21 Coen Steven P. Officer (See remarks) Option exercise / conversion 156 Form 4
2026-05-21 Coen Steven P. Officer (See remarks) Option exercise / conversion 587 Form 4
2026-04-17 Coen Steven P. Officer (See remarks) Open-market sale 324 $7.95 $2.6K Form 4
2026-04-16 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 156 Form 4
2026-04-16 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 587 Form 4
2026-04-16 Coen Steven P. Officer (See remarks) Option exercise / conversion 156 Form 4
2026-04-16 Coen Steven P. Officer (See remarks) Option exercise / conversion 587 Form 4
2026-04-13 Coen Steven P. Officer (See remarks) Open-market sale 33,171 $6.41 $212.8K Form 4
2026-04-10 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 45,553 Form 4
2026-04-10 Coen Steven P. Officer (See remarks) Option exercise / conversion (derivative) 28,368 Form 4
2026-04-10 Coen Steven P. Officer (See remarks) Option exercise / conversion 45,553 Form 4
2026-04-10 Coen Steven P. Officer (See remarks) Option exercise / conversion 28,368 Form 4
2026-04-10 Shetty Reshma P. Director, Officer (See remarks), 10% owner Open-market sale 124,727 $6.43 $802.5K Form 4
2026-04-10 Canton Barry 10% owner Open-market sale 124,727 $6.43 $802.5K Form 4
2026-04-09 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion (derivative) 251,786 Form 4
2026-04-09 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion 251,786 Form 4
2026-04-09 Canton Barry 10% owner Option exercise / conversion (derivative) 251,786 Form 4
2026-04-09 Canton Barry 10% owner Option exercise / conversion 251,786 Form 4
2026-04-09 Kelly Jason R Director, Officer (See remarks) Open-market sale 109,767 $6.40 $702.2K Form 4
2026-04-09 Canton Barry 10% owner Open-market sale 13,116 $6.40 $83.9K Form 4
2026-04-09 Shetty Reshma P. Director, Officer (See remarks), 10% owner Open-market sale 13,116 $6.40 $83.9K Form 4
2026-04-08 Kelly Jason R Director, Officer (See remarks) Option exercise / conversion (derivative) 212,949 Form 4
2026-04-08 Kelly Jason R Director, Officer (See remarks) Open-market sale 97,015 $6.93 $672.3K Form 4
2026-04-08 Kelly Jason R Director, Officer (See remarks) Option exercise / conversion 212,949 Form 4
2026-04-08 Canton Barry 10% owner Option exercise / conversion (derivative) 27,738 Form 4
2026-04-08 Canton Barry 10% owner Open-market sale 13,155 $6.93 $91.2K Form 4
2026-04-08 Canton Barry 10% owner Option exercise / conversion 27,738 Form 4
2026-04-08 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion (derivative) 27,738 Form 4
2026-04-08 Shetty Reshma P. Director, Officer (See remarks), 10% owner Open-market sale 13,155 $6.93 $91.2K Form 4
2026-04-08 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion 27,738 Form 4
2026-04-07 Kelly Jason R Director, Officer (See remarks) Option exercise / conversion (derivative) 212,949 Form 4
2026-04-07 Kelly Jason R Director, Officer (See remarks) Option exercise / conversion 212,949 Form 4
2026-04-07 Canton Barry 10% owner Option exercise / conversion (derivative) 27,738 Form 4
2026-04-07 Canton Barry 10% owner Option exercise / conversion 27,738 Form 4
2026-04-07 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion (derivative) 27,738 Form 4
2026-04-07 Shetty Reshma P. Director, Officer (See remarks), 10% owner Option exercise / conversion 27,738 Form 4

Ask the chat about DNA's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: GINKGO BIOWORKS HOLDINGS INC CLASS (DNA).

Last updated 2026-06-11 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.